Search research articles
Contact Us
Filters
Showing results (761-770 of 935) with videos related to
Page
of 94
Sort By:
Trials
|
November 13, 2025
Study protocol for a multicenter, multinational prospective randomized controlled trial comparing outcomes in subjects with Gram-negative bacteremia who have blood culture evaluation using Fast Antibiotic Susceptibility Testing vs. standard of care testing: the FAST trial
Ritu Banerjee, Lauren Komarow, Yixuan Li, et al.
Science Translational Medicine
|
August 9, 2023
Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens
Jinshi Zhao, C Skyler Cochrane, Javaria Najeeb, et al.
Open Forum Infectious Diseases
|
June 24, 2026
Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections
Jessica Howard-Anderson, Toshimitsu Hamasaki, Lizhao Ge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2018
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection
Sarah B Doernberg, Thuy Tien Tram Tran, Steven Y C Tong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 23, 2023
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Jessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Annals of the American Thoracic Society
|
December 25, 2015
Potential Cost-effectiveness of Early Identification of Hospital-acquired Infection in Critically Ill Patients
Ephraim L Tsalik, Yanhong Li, Lori L Hudson, et al.
Antimicrobial Agents and Chemotherapy
|
January 30, 2024
<i>In vitro</i> activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant <i>Acinetobacter baumannii</i> collected in U.S. hospitals
Alina Iovleva, Christi L McElheny, Erin L Fowler, et al.
JAMA
|
April 18, 2026
Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia: The FAST Randomized Clinical Trial
Ritu Banerjee, Lauren Komarow, Yixuan Li, et al.
Journal of Intensive Care
|
November 22, 2018
Evaluating the discriminating capacity of cell death (apoptotic) biomarkers in sepsis
Christopher Duplessis, Michael Gregory, Kenneth Frey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin, Judith J Lok, Michelle Earley, et al.
Page
of 94
Search research articles
Search
Showing results (761-770 of 935) with videos related to
Sort By:
Page
of 94
Trials
|
November 13, 2025
Study protocol for a multicenter, multinational prospective randomized controlled trial comparing outcomes in subjects with Gram-negative bacteremia who have blood culture evaluation using Fast Antibiotic Susceptibility Testing vs. standard of care testing: the FAST trial
Ritu Banerjee, Lauren Komarow, Yixuan Li, et al.
Science Translational Medicine
|
August 9, 2023
Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens
Jinshi Zhao, C Skyler Cochrane, Javaria Najeeb, et al.
Open Forum Infectious Diseases
|
June 24, 2026
Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections
Jessica Howard-Anderson, Toshimitsu Hamasaki, Lizhao Ge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2018
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection
Sarah B Doernberg, Thuy Tien Tram Tran, Steven Y C Tong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 23, 2023
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Jessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Annals of the American Thoracic Society
|
December 25, 2015
Potential Cost-effectiveness of Early Identification of Hospital-acquired Infection in Critically Ill Patients
Ephraim L Tsalik, Yanhong Li, Lori L Hudson, et al.
Antimicrobial Agents and Chemotherapy
|
January 30, 2024
<i>In vitro</i> activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant <i>Acinetobacter baumannii</i> collected in U.S. hospitals
Alina Iovleva, Christi L McElheny, Erin L Fowler, et al.
JAMA
|
April 18, 2026
Fast Antimicrobial Susceptibility Testing for Gram-Negative Bacteremia: The FAST Randomized Clinical Trial
Ritu Banerjee, Lauren Komarow, Yixuan Li, et al.
Journal of Intensive Care
|
November 22, 2018
Evaluating the discriminating capacity of cell death (apoptotic) biomarkers in sepsis
Christopher Duplessis, Michael Gregory, Kenneth Frey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin, Judith J Lok, Michelle Earley, et al.
Page
of 94